Compare Ally Financial Inc (ALLY) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ally Financial Inc vs Johnson & Johnson — how do they compare? Ally Financial Inc trades at $44.62 (market cap $13.46B), while Johnson & Johnson trades at $262.21 (market cap $628.65B). The key difference: Johnson & Johnson is far larger — about 46.7× Ally Financial Inc's market cap, and Ally Financial Inc pays the higher dividend (2.71%). Which is the better fit depends on your goals.
| ALLY | JNJ | |
|---|---|---|
Market Cap | $13.46B | $628.65B |
Sector | Financials | Health |
52-Week High | $47.25 | $267.24 |
52-Week Low | $35.96 | $174.16 |
Dividend Yield | 2.71% | 2.05% |
Volume | — | 6,156,228 |
Enterprise Value | — | $656.92B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ally Financial trades at $44.60, up 1.48% with neutral technical signals. The company shows stable fundamentals with a P/E of 10.41 and recent earnings beats in three of the last four quarters. Recent news includes insider sales and Q2 2026 earnings miss, while maintaining strong analyst support with 68% buy ratings and a $54.40 consensus target.
Ally presents value opportunity with attractive valuation metrics and dividend yield, though faces headwinds from rising provisions and competitive pressures. The stock offers 22% upside to consensus target but requires monitoring of credit quality trends and interest rate sensitivity in the auto lending sector.
Johnson & Johnson (JNJ) trades at $262.08, up 0.88% with a bullish technical outlook supported by moving averages. The company demonstrates strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend growth spanning 64 years. Recent earnings show beats in Q1 and Q2 2026, while analysts maintain a buy consensus with a $284.50 price target representing 8.5% upside potential.
JNJ offers stable growth with defensive characteristics but faces headwinds from patent expirations and legal challenges. The stock trades at a premium valuation (P/E 30.26) but justifies it with robust profitability (ROE 25.74%). Current price near 52-week highs suggests limited near-term upside without new catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ally Financial Inc
Ally Financial Inc is a diversified financial services firm that services automotive dealers and their retail customers. The company operates as a financial holding company and a bank holding company. Its banking subsidiary, Ally Bank, caters to the direct banking market through Internet, mobile, and mail. The company reports four business segments including Automotive Finance operations, Insurance operations, Mortgage Finance operations and Corporate Finance operations.
Read more on ALLY →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
